摘要
外阴癌为外阴的恶性肿瘤,约占女性全身恶性肿瘤的1%,女性生殖道恶性肿瘤3%~5%,多见于60岁以上妇女,发病率随着年龄的增长而增加。80%~90%的原发性外阴癌为鳞状细胞癌,另外还有恶性黑色素瘤、腺癌、基底细胞癌、疣状癌、肉瘤及其他罕见的外阴恶性肿瘤。
出处
《实用妇产科杂志》
CAS
CSCD
北大核心
2011年第6期404-406,共3页
Journal of Practical Obstetrics and Gynecology
参考文献3
-
1Hacker NF. Revised FIGO staging for carcinoma of the vulva [J].Int J Gynecol Obstet, 2009, 105(2) : 103 -106.
-
2沈铿,彭澎,吴鸣.国际妇产科联盟妇科肿瘤2009年分期的解读[J].中华妇产科杂志,2010,45(10):721-724. 被引量:37
-
3van der Steen S, de Nieuwenhof HP, Massuger L, et al. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis [J]. Gynecol Oncol, 2010, 119(3) : 520 -525.
二级参考文献15
-
1Prat J.FIGO staging for uterine sarcoma.Int J Gynecol Obstet,2009,104:177-179.
-
2Pecorelli S,Revised FIGO staging for carcinoma of the vulva,cervix,and endometrium.Int J Gynecol Obstet,2009,105:103-104.
-
3Kim HS,Song YS.International Federation of Gynecology and Obstetrics (FIGO) staging system revised:what should be considered critically for gynecologic cancer? J Gynecol Oncol,2009,20:135-136.
-
4Hacker NF.Revised FIGO staging for carcinoma of the vulva.Int J Gynecol Obstet,2009,105:105-106.
-
5Hacker NF,Berek JS,Lagasse LD,et al.Management of regional lymph nodes and their prognostic influence in vulvar cancer.Obstet Gynecol,1983,61:408-412.
-
6Homesley HD,Bundy BN,Sedlis A,et al.Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study).Am J Obstet Gynecol,1991,164:997-1004.
-
7Origoni M,Sideri M,Garsia S,et al.Prognostic value of pathological patterns of lymph node positivity in squamous cell carcinoma of the vulva stage Ⅲ and Ⅳ A FIGO.Gynecol Oncol,1992,45:313-316.
-
8Pecorelli S,Zigliani L,Odicino F.Revised FIGO staging for carcinoma of the cervix.Int J Gynecol Obstet,2009,105:107-108.
-
9Delgado G,Bundy B,Zaino R,et al.Prospective surgicalpathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix:a Gynecologic Oncology Group study.Gynecol Oncol,1990,38:352-357.
-
10Perez CA,Grigsby PW,Chao KS,et al.Tumor size,irradiation dose,and long-term outcome of carcinoma of uterine cervix.Int J Radiat Oncol Biol Phys,1998,41:307-317.
共引文献36
-
1沈铿.传承、感恩和发展[J].中华妇产科杂志,2013,48(4):307-309.
-
2黄丽云,许羚雁,何金龙.人附睾分泌蛋白4联合CA125检测在卵巢癌筛查鉴别中的意义[J].中国肿瘤临床与康复,2013,20(8):816-818. 被引量:3
-
3陆英华,吴亦波.TC化疗联合放疗治疗术后高危子宫内膜癌的疗效观察[J].现代药物与临床,2014,29(11):1253-1256. 被引量:14
-
4高琴,张丹丹,白帆,罗芳,李芳兵.紫杉醇联合铂类方案治疗中晚期宫颈癌患者的临床疗效及对血清CYFRA21-1、SCC-Ag的影响[J].疑难病杂志,2015,14(1):53-56. 被引量:26
-
5曹桂英.血管内皮生长因子和细胞分化抑制因子联合检测在宫颈癌诊疗中的应用价值[J].中国基层医药,2015,22(5):696-699. 被引量:1
-
6马莉娟,何金彩,柴泽英.细胞分化抑制因子-1与细胞增殖核抗原Ki-67在宫颈癌中的表达及相关性研究[J].中国临床药理学杂志,2015,31(8):627-630. 被引量:41
-
7王诗章,程卫.有生殖要求卵巢恶性生殖细胞肿瘤患者手术治疗的方式及疗效[J].国际医药卫生导报,2016,22(19):2936-2939.
-
8李国强,罗敬,郑志坚,陈爱辉.VMAT联合同期化疗治疗中晚期宫颈癌临床研究[J].内科,2017,12(3):309-311. 被引量:1
-
9梁曼霞.扶正解毒汤辅助放化疗治疗晚期宫颈癌48例临床观察[J].中国中医药科技,2017,24(3):352-354. 被引量:9
-
10王建瑞,韩滨,李珂.脂肪酸合成酶在卵巢癌组织中的表达及其与临床特征的关系研究[J].癌症进展,2018,16(6):760-762. 被引量:1
同被引文献16
-
1Parkin DM. The global health burden of in fection-assodated cancers in the year 2002 [J]. Int J Cancer,2006,118(12) :3030-3044.
-
2Gillison ML, Chaturvedi AK, Lowy DR. HPV prophylactic vaccines and the potential prevention of noncervical can cers in both men and women[J]. Cancer, 2008,113 (Suppl 10) : 3035-3046.
-
3Smith JS,gackes DIM, Hoots BE, el al. Human papillomavirus type- distribution in vulvar and vallinal cancers and their assodated precur- sors[J]. Obstet Gynecol,2009,113(4):917-924.
-
4Knopp S, Trope C, Nesland JM, et al. A review of molecular patho- logical markers in vulvar carcinoma: Lack of application in clinical praetice[J]. J Clin Pathol,2009,62(3) :212-218.
-
5Tapp RA,Feng J,Jones JW,et al. Single base instability is promoted in vulvar lichen sclerosus[J].J Invest Dermatol, 2007, 127 (11): 2563-2576.
-
6Kruse AJ, Bottenberg M], Tosserams J, et al. The absence of high- risk HPV combined with specific p53 and p16INK4a expression pat- terns points to the HPV-independent pathway as the causative agent for vulvar squamous cell carcinoma and its precursor simplex VIN in a young patient[J]. Int J Gynecol Pathol,2008,27(4) :591-595.
-
7Courtney-Brooks M, Sukumvanich P, Beriwal S, et al. Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease [J].Gynecol Oncol, 2010, 117 ( 2 ) : 308-311.
-
8Daradrian TS, Gray HJ, Morgan MA, et al. Saphenous vein sparing during inguinal lyrnphadenectomy to reduce morbidity in patients with vulvar cardnoma[J]. Gynecol Oncol, 2006,101 (1) : 140-142.
-
9冯艳玲,刘继红.外阴癌和阴道癌早期诊断及预防[J].中国实用妇科与产科杂志,2010,26(9):669-672. 被引量:4
-
10沈铿,孙建衡,曹泽毅,陈春玲,彭芝兰,孔北华,谢幸,向阳,刘继红,陈亦乐,魏丽惠,吴小华,郎景和.国际妇产科联盟妇科肿瘤2009年分期的临床意义研讨[J].中华妇产科杂志,2010,45(10):725-731. 被引量:14
-
1刘丹丹.外阴恶性肿瘤临床治疗方法[J].世界最新医学信息文摘,2013,13(20):182-182.
-
2岳新华.疣状癌中PCNA和p53蛋白表达的对比分析[J].临床与实验病理学杂志,1999,15(4):364-364.
-
3孟刚,龚西騟,王保太,李新建.皮肤疣状癌[J].临床与实验病理学杂志,1993,9(4):297-298. 被引量:1
-
4李宁,杨秋花,曹积功.外阴恶性肿瘤治疗10例分析[J].中国误诊学杂志,2002,2(2):287-288. 被引量:2
-
5张育军,魏丽惠,等.抑癌基因PTEN在子宫内膜癌组织中的表达[J].中华妇产科杂志,2002,37(6):374-375. 被引量:5
-
6李庆水,盛修贵,梁焕玲,马悦冰,刘乃富,李庆菊.外阴恶性肿瘤腹股沟淋巴结转移与预后的关系[J].中国妇产科临床杂志,2000,1(1):35-36.
-
7吕仁荣,禚莹莹,霍然,孙茜.疣状癌6例临床分析[J].中国麻风皮肤病杂志,2008,24(3):218-218. 被引量:1
-
8潘忠勉,李力.原发性外阴癌50例临床分析[J].广西医科大学学报,2007,24(5):752-753.
-
9韩明明,郭志利,张晓娟.宫颈癌的放射治疗研究[J].中国冶金工业医学杂志,2016,33(6):632-633. 被引量:3
-
10徐关德,蔡红光.子宫肌瘤合并子宫内膜癌的术前诊断[J].现代实用医学,2001,13(7):351-351. 被引量:1